IRCT20110509006420N17RecruitingPhase 3
Intrauterine infusion of autologous platelet-rich plasma in women with Asherman's syndrome
Yazd University of Medical Sciences0 sites30 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Sponsor
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 45 years (—)
- Sex
- Female
Inclusion Criteria
- •All patients with Asherman's syndrome who have been diagnosed with ultrasound, sonography, hysterography or hysteroscopy.
Exclusion Criteria
- •Severe cervical stenosis
- •Coagulation disorders
- •Mullerian anomaly
- •systemic disorders
Investigators
Similar Trials
Recruiting
Phase 2
For Increase in Endometrial Thickness in Women With Thin Endometrium undergoing Infertility Treatment use of Intrauterine Infusion Of Autologous Platelet Rich Plasma (PRP) and Granulocyte Colony Stimulating Factor (G-CSF)CTRI/2024/03/064601Datta megha institute of higher education and research
Completed
Not Applicable
Role of autologous Platelet rich plasma in infertile females.CTRI/2021/05/033764vmmc and safdarjung hospital delhi
Completed
Unknown
Role of platelet rich plasma in infertile females with thin endometriumCTRI/2022/05/042399not applicable
Recruiting
Phase 1
Intrauterine administration of autologous PBMC in patients with RIF.infertile womanrepeated implantation failureJPRN-jRCTc050190121Mandai Masaki200
Recruiting
Not Applicable
Intrauterine administration of autologous peripheral blood mononuclear cells in patients with repeated implantation failure.patients with repeated implantation failureJPRN-UMIN000022434Kyoto University100